The oxygen paradox in retinopathy of prematurity: could fetal hemoglobin be the key? - Scorecard - MDSpire

The oxygen paradox in retinopathy of prematurity: could fetal hemoglobin be the key?

  • By

  • Marcus T. A. Jackson

  • Ronny Amamoo

  • Menaka C. Thounaojam

  • Pamela M. Martin

  • Ravirajsinh N. Jadeja

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: The Role of Fetal Hemoglobin in the Oxygen Paradox of Retinopathy of Prematurity

At a Glance

CategoryDetail
ConditionRetinopathy of Prematurity (ROP)
Key MechanismsPostnatal decline in fetal hemoglobin (HbF) associated with increased ROP risk; transfusions from adult donors accelerate HbF replacement with adult hemoglobin (HbA).
Target PopulationPreterm infants, particularly those between 31 and 34 weeks postmenstrual age.
Care SettingNeonatal intensive care units.

Key Highlights

  • Lower HbF levels correlate with increased incidence and severity of ROP.
  • Red blood cell transfusions from adult donors accelerate HbF decline.
  • HbF's higher oxygen affinity may protect against hyperoxic injury in the retina.
  • Transfusion practices significantly influence ROP risk.
  • HbF levels can serve as predictive biomarkers for ROP risk.

Guideline-Based Recommendations

Diagnosis

  • Monitor HbF levels in preterm infants to assess ROP risk.

Management

  • Optimize transfusion practices to minimize HbF decline.

Monitoring & Follow-up

  • Routine HbF monitoring as part of ROP preventive strategies.

Risks

  • Increased risk of ROP associated with early and repeated transfusions.

Patient & Prescribing Data

Preterm infants, particularly those at risk for ROP.

Selective use of cord blood products and HbF-informed oxygen titration may mitigate ROP risk.

Clinical Best Practices

  • Implement HbF stewardship to guide transfusion and oxygen management.
  • Consider timing and frequency of transfusions to reduce ROP risk.

Related Resources & Content

Original Source(s)

Related Content